DTIL – Precision BioSciences, Inc.
Precision BioSciences, Inc.DTIL
$5.02Name : Precision BioSciences, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $52,961,500.00
EPSttm : 1.04
Precision BioSciences, Inc.
$5.02
0.20%$0.01Float Short %
25.34
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.65
EPS Last/This Y
-11.27
EPS This/Next Y
1.2
Price
5.02
Target Price
35.75
Analyst Recom
1
Performance Q
6.36
Relative Volume
0.62
Beta
1.48
Ticker: DTIL
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-21 | DTIL | 5.4 | N/A | N/A | 0 |
| 2025-03-24 | DTIL | 5.68 | N/A | N/A | 0 |
| 2025-03-25 | DTIL | 5.15 | N/A | N/A | 0 |
| 2025-03-26 | DTIL | 4.53 | N/A | N/A | 0 |
| 2025-03-27 | DTIL | 4.53 | N/A | N/A | 0 |
| 2025-03-28 | DTIL | 4.66 | N/A | N/A | 0 |
| 2025-03-31 | DTIL | 4.77 | N/A | N/A | 0 |
| 2025-04-01 | DTIL | 4.4 | N/A | N/A | 0 |
| 2025-04-02 | DTIL | 4.65 | N/A | N/A | 0 |
| 2025-04-03 | DTIL | 4.68 | N/A | N/A | 0 |
| 2025-04-04 | DTIL | 4.57 | N/A | N/A | 0 |
| 2025-04-07 | DTIL | 4.38 | N/A | N/A | 0 |
| 2025-04-08 | DTIL | 4.62 | N/A | N/A | 0 |
| 2025-04-09 | DTIL | 4.51 | N/A | N/A | 0 |
| 2025-04-10 | DTIL | 4.2 | N/A | N/A | 0 |
| 2025-04-11 | DTIL | 4.43 | N/A | N/A | 0 |
| 2025-04-14 | DTIL | 4.47 | N/A | N/A | 0 |
| 2025-04-15 | DTIL | 5.52 | N/A | N/A | 0 |
| 2025-04-16 | DTIL | 5.01 | N/A | N/A | 0 |
| 2025-04-17 | DTIL | 4.95 | N/A | N/A | 0 |
| 2025-04-18 | DTIL | 5.02 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-21 | DTIL | 5.47 | - | - | 1.03 |
| 2025-03-24 | DTIL | 5.64 | - | - | 1.03 |
| 2025-03-25 | DTIL | 5.09 | - | - | 1.03 |
| 2025-03-26 | DTIL | 4.53 | - | - | 1.03 |
| 2025-03-27 | DTIL | 4.58 | - | - | 1.03 |
| 2025-03-28 | DTIL | 4.70 | - | - | -8.62 |
| 2025-03-31 | DTIL | 4.72 | - | - | -8.62 |
| 2025-04-01 | DTIL | 4.49 | - | - | -8.62 |
| 2025-04-02 | DTIL | 4.69 | - | - | -8.62 |
| 2025-04-03 | DTIL | 4.67 | - | - | -8.62 |
| 2025-04-04 | DTIL | 4.59 | - | - | -10.22 |
| 2025-04-07 | DTIL | 4.41 | - | - | -10.22 |
| 2025-04-08 | DTIL | 4.62 | - | - | -10.22 |
| 2025-04-09 | DTIL | 4.55 | - | - | -10.22 |
| 2025-04-10 | DTIL | 4.26 | - | - | -10.22 |
| 2025-04-11 | DTIL | 4.39 | - | - | -10.22 |
| 2025-04-14 | DTIL | 4.46 | - | - | -10.22 |
| 2025-04-15 | DTIL | 5.52 | - | - | -10.22 |
| 2025-04-16 | DTIL | 5.04 | - | - | -10.22 |
| 2025-04-17 | DTIL | 5.02 | - | - | -10.22 |
| 2025-04-18 | DTIL | 5.02 | - | - | -10.22 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-21 | DTIL | -5.37 | 18.86 | 20.13 |
| 2025-03-24 | DTIL | -5.37 | 18.86 | 21.29 |
| 2025-03-25 | DTIL | -3.62 | 18.86 | 21.29 |
| 2025-03-26 | DTIL | -3.70 | 18.86 | 17.87 |
| 2025-03-27 | DTIL | -3.44 | 18.86 | 17.87 |
| 2025-03-28 | DTIL | -2.22 | 18.86 | 17.87 |
| 2025-03-31 | DTIL | -2.22 | 13.57 | 17.87 |
| 2025-04-01 | DTIL | -2.22 | 13.57 | 17.92 |
| 2025-04-02 | DTIL | -2.20 | 13.57 | 17.92 |
| 2025-04-03 | DTIL | -2.20 | 13.57 | 17.92 |
| 2025-04-04 | DTIL | -2.20 | 13.57 | 17.92 |
| 2025-04-07 | DTIL | -2.20 | 45.26 | 17.92 |
| 2025-04-08 | DTIL | -2.20 | 45.26 | 17.92 |
| 2025-04-09 | DTIL | -2.20 | 45.26 | 17.92 |
| 2025-04-10 | DTIL | -2.20 | 45.26 | 21.82 |
| 2025-04-11 | DTIL | -2.20 | 45.26 | 21.82 |
| 2025-04-14 | DTIL | -5.49 | 45.41 | 21.82 |
| 2025-04-15 | DTIL | -5.49 | 45.41 | 21.82 |
| 2025-04-16 | DTIL | -2.20 | 45.41 | 21.82 |
| 2025-04-17 | DTIL | -2.20 | 45.41 | 21.82 |
| 2025-04-18 | DTIL | -2.20 | 45.41 | 25.34 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-3.2
Avg. EPS Est. Current Quarter
-0.39
Avg. EPS Est. Next Quarter
-2.55
Insider Transactions
-2.2
Institutional Transactions
45.41
Beta
1.48
Average Sales Estimate Current Quarter
10
Average Sales Estimate Next Quarter
6
Fair Value
Quality Score
59
Growth Score
46
Sentiment Score
77
Actual DrawDown %
99
Max Drawdown 5-Year %
-99.2
Target Price
35.75
P/E
2.65
Forward P/E
PEG
P/S
0.77
P/B
0.73
P/Free Cash Flow
EPS
1.89
Average EPS Est. Cur. Y
-10.22
EPS Next Y. (Est.)
-9.02
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
10.43
Relative Volume
0.62
Return on Equity vs Sector %
-7.3
Return on Equity vs Industry %
6.1
EPS 1 7Days Diff
-1.6
EPS 1 30Days Diff
-1.6
EBIT Estimation
Precision BioSciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 108
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision in the United States. It offers ARCUS, a genome editing platform to DNA genome insertion, deletion, and repair. The company also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; PBGENE-PMM for the treatment of m.3243 associated primary mitochondrial myopathy (PMM) which is expected to submit an IND and/or CTA. In addition, it develops PBGENE-NVS for sickle cell disease/beta thalassemia for insertion; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. The company has license and collaboration agreement with Caribou Biosciences, Inc.; license agreement with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; Cellectis S.A.; iECURE, Inc. to develop ARCUS-based gene-insertion therapies; Duke University; and Novartis Pharma AG to discover and develop in vivo gene editing products. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
stock quote shares DTIL – Precision BioSciences, Inc. Stock Price stock today
news today DTIL – Precision BioSciences, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DTIL – Precision BioSciences, Inc. yahoo finance google finance
stock history DTIL – Precision BioSciences, Inc. invest stock market
stock prices DTIL premarket after hours
ticker DTIL fair value insiders trading